ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 210 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,671 | -16.5% | 5,339 | -14.1% | 0.06% | -11.6% |
| Q2 2023 | $3,200 | +43.0% | 6,213 | +3.5% | 0.07% | +30.2% |
| Q1 2023 | $2,237 | +9.3% | 6,004 | +11.1% | 0.05% | +3.9% |
| Q4 2022 | $2,046 | -99.9% | 5,403 | -2.6% | 0.05% | -5.6% |
| Q3 2022 | $1,958,000 | -9.7% | 5,545 | -3.1% | 0.05% | -3.6% |
| Q2 2022 | $2,168,000 | +22.6% | 5,722 | +2.1% | 0.06% | +43.6% |
| Q1 2022 | $1,768,000 | -0.5% | 5,607 | +10.5% | 0.04% | 0.0% |
| Q4 2021 | $1,777,000 | +3.9% | 5,074 | -10.4% | 0.04% | -2.5% |
| Q3 2021 | $1,711,000 | +8.0% | 5,665 | +7.7% | 0.04% | +8.1% |
| Q2 2021 | $1,584,000 | +5.7% | 5,260 | -3.3% | 0.04% | 0.0% |
| Q1 2021 | $1,499,000 | -10.0% | 5,442 | -3.9% | 0.04% | -11.9% |
| Q4 2020 | $1,665,000 | +15.7% | 5,662 | +3.3% | 0.04% | +5.0% |
| Q3 2020 | $1,439,000 | +12.6% | 5,483 | -3.4% | 0.04% | +8.1% |
| Q2 2020 | $1,278,000 | – | 5,675 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 49,950 | $14,690,000 | 5.25% |
| Avoro Capital Advisors LLC | 902,500 | $265,416,000 | 4.57% |
| Eagle Health Investments LP | 19,587 | $5,760,000 | 3.68% |
| Redmile Group, LLC | 918,307 | $270,065,000 | 3.27% |
| Bellevue Group AG | 945,348 | $278,018,000 | 3.18% |
| AWM Investment Company, Inc. | 80,000 | $23,527,000 | 2.99% |
| DCF Advisers, LLC | 24,000 | $7,058,000 | 2.91% |
| Ikarian Capital, LLC | 201,500 | $59,260,000 | 2.61% |
| JGP Global Gestao de Recursos Ltda. | 1,859 | $547,000 | 2.06% |
| Evolutionary Tree Capital Management, LLC | 8,798 | $2,587,000 | 1.97% |